Silence Therapeutics plc (SLN) earnings

  • Healthcare
  • NASDAQ
  • Market cap$936M

Next report

2027-03-04

In 103 daysQ4 FY2026Time not announced· Expected date
EPS consensus
-0.09
-0.12 – -0.102 analysts
Revenue consensus
$9.00K

Latest result

9 days ago

⁦-112.6%⁩

A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages

Estimate recorded after the release

2026-11-12Q3 FY2026BMO
EPS
Reported / estimate-0.24 / -0.11
Revenue
— / $113K

Stock reaction

⁦+0.15%⁩

⁦+0.51⁩ pts vs SPY

Session ⁦2026-11-12⁩

Recent quarters

Latest 3 quarters

Revenue and stock reaction

Beat in 1 of 2 quarters with a measured stock reaction · beat then fell 1

Reported / estimate

  • Q3 FY2026 · 2026-11-12+0.15%
    EPS-0.24 / -0.11-112.6%‡
    Revenue— / $113K
  • Q2 FY2026 · 2026-08-10+29.12%
    EPS-0.26 / -0.14-87.5%
    Revenue$137K / $1.17M-88.3%
  • Q1 FY2026 · 2026-05-07-5.57%
    EPS-0.32 / -0.33+3.0%
    Revenue$422K / $1.25M-66.4%
  • ‡A surprise beyond ±100% is usually a one-off item or a different basis, so it is left out of averages
  • Estimate recorded after the releaseNo estimate was saved before the results came out, so the surprise is measured against an estimate recorded after the release.

Reaction is the close of the reacting session versus the previous close. The gap to SPY is in percentage points.